Filter Results
:
(140)
Show Results For
-
All HBS Web
(334)
- People (1)
- News (131)
- Research (140)
- Multimedia (13)
- Faculty Publications (84)
Show Results For
-
All HBS Web
(334)
- People (1)
- News (131)
- Research (140)
- Multimedia (13)
- Faculty Publications (84)
←
Page 7 of
140
Results
Sort by
- 15 Dec 2020
- Research & Ideas
The Unspoken Messages of COVID-19 Restrictions
restrictions—may need to refine their outreach to a pandemic-weary public, especially when it comes to high-risk activities, such as indoor dining. As vaccine hopes and holiday loneliness make distancing harder, consumers will need more...
View Details
- 22 Mar 2016
- First Look
March 22, 2016
Vaccinations Evive Health is a company that manages communication campaigns on behalf of health insurance plans and large employers. Using big data techniques and insights from behavioral economics, Evive deploys targeted and effective...
View Details
Keywords:
Sean Silverthorne
- 20 Jan 2015
- First Look
First Look: January 20
School Case 514-084 Vision 2020: Takeda and the Vaccine Business In 2014, Yasuchika Hasegawa was orchestrating the transformation of Takeda from a Japanese pharmaceutical company with a global footprint into a global company with a...
View Details
Keywords:
Sean Silverthorne
- 20 May 2016
- Op-Ed
World Health Organization Lacks Leadership to Combat Pandemics
greater role in WHO governance and if there are guarantees of purchase contracts for new drugs and vaccines at sensible prices. Both seem unlikely, as the WHO's culture has always winced at cooperation with the private sector. WHO's track...
View Details
- 19 Jan 2021
- In Practice
Leadership Advice for Biden: Restore a Sense of Calm
Joseph R. Biden Jr. becomes the 46th president of the United States at a time when the nation is grappling with several sober realities at once: a deadly pandemic that is claiming the lives of thousands of Americans daily, a bumpy vaccine...
View Details
Keywords:
by Dina Gerdeman
- 12 Dec 2022
- Research & Ideas
Buy-In from Black Patients Suffers When Drug Trials Don’t Include Them
Moderna, a pharmaceutical company, announced in September 2020 that it would slow enrollment of its COVID-19 vaccine trials to better improve representation. The majority of study participants were white, although COVID-19 was...
View Details
- 07 Aug 2012
- First Look
First Look: August 7
case:http://hbr.org/search/812158-PDF-ENG GlaxoSmithKline in Brazil: Public-Private Vaccine Partnerships Arthur A. Daemmrich and Ian McKown CornellHarvard Business School Case 712-049 Three years into a major public-private partnership...
View Details
Keywords:
Sean Silverthorne
- 27 May 2020
- Research & Ideas
What South Korea Teaches the World About Fighting COVID
spread of COVID-19 with proactive and reactive testing Mass production, distribution, and promotion of face masks In the absence of a vaccine or a treatment, there are only two interventions that can prevent the spread of the virus—social...
View Details
- 16 Jun 2015
- First Look
First Look: June 16, 2015
particularly in the vaccine space, had begun to attract the attention of much larger pharmaceutical companies. While there was much appeal to working with these companies, these relationships could also challenge Crucell's independence....
View Details
Keywords:
Sean Silverthorne
- 23 May 2017
- First Look
First Look at New Ideas and Research: May 23, 2017
Although Novartis would improve its position in oncology by acquiring GSK’s promising drug portfolio, it had to sell its vaccines and animal health businesses, while giving up control of the over-the-counter (OTC) business. Jimenez and...
View Details
Keywords:
Carmen Nobel
- 04 Feb 2021
- Research & Ideas
Inside CEOs' Pandemic Worries: Uncertainty, Employees, and Kids
understanding when to use which medium of communication (email, telephone, Zoom).” Searching for the silver linings The new year began with promising vaccine developments, giving CEOs some rational hope, but there is still a long, dark,...
View Details
- 08 Dec 2015
- First Look
December 8, 2015
these? Plan-making, a tool that leverages research on memory and cognition as well as mechanical benefits of scheduling, is one underappreciated solution. We review experiments showing that forming specific, concrete plans increases follow through across a range of...
View Details
Keywords:
Sean Silverthorne
- 03 Mar 2009
- First Look
First Look: March 3, 2009
The use of Tamiflu in such a crisis would allow the world to respond immediately, rather than having to wait for development of a vaccine which had limitations in its effectiveness, and the drug had been endorsed by the WHO as a first...
View Details
Keywords:
Martha Lagace
- ←
- 7